Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Harmesh Naik"'
Autor:
David Smith, Rajesh R. Bandekar, Kenneth J. Pienta, Bruce G. Redman, Kemp B. Cease, Harmesh Naik, Peggy S. Esper, Myla Strawderman
Publikováno v:
Urology. 50:401-407
Objectives We previously demonstrated that the combination of oral estramustine (15 mg/kg/day) and oral etoposide (50 mg/m 2 /day) is effective first-line therapy for the treatment of hormone refractory prostate cancer. We initiated a new Phase II tr
Publikováno v:
Urology. 48:164-170
Publikováno v:
Urology. 48(3)
Objectives Hormone-refractory prostate cancer continues to be associated with a very poor prognosis. Agents that interact with the nuclear matrix have been demonstrated to have activity against hormonerefractory prostate cancer. It was the aim of thi
Publikováno v:
Advances in Pharmacology ISBN: 9780120329342
Publisher Summary It has been suggested that ultimately half of all cancers might be prevented by early interventions. N -4-hydroxyphenylretinamide (4HPR or fenretinide) has been shown to be an effective and safe agent in various in vivo animal trial
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::163d80cc024bd8d5818b2cd5165d8635
https://doi.org/10.1016/s1054-3589(08)60673-0
https://doi.org/10.1016/s1054-3589(08)60673-0
Publikováno v:
International Journal of Oncology.
Hormone refractory prostate cancer remains an incurable disease and the discovery of newer agents with higher cytotoxic activity is required. Gossypol is a phenolic compound isolated from cottonseed oil which has been shown to have anti-spermatogenic
Publikováno v:
Clinical Infectious Diseases. 21:1514-1515